Newsroom

LATEST NEWS

Press Release

Oct 23, 2020

Canada’s Prime Minister, Justin Trudeau, Announced Today Precision NanoSystems Will Receive $18.2 Million from the Government of Canada to Develop an RNA Vaccine for COVID-19

Precision Nanosystems, Inc., a global leader in technologies and solutions in genetic medicine, announced today that it has received a commitment of up to $18.2 million in support from the Government of Canada under the Innovation, Science and Economic Development’s (ISED) ...

News
Events

PRESS RELEASES

Press Release

Jul 07, 2020

eTheRNA Immunotherapies Selects Precision NanoSystems’ NxGen™ Technology for GMP Manufacturing

eTheRNA Immunotherapies NV (eTheRNA) and Precision NanoSystems Inc. (PNI) have signed a license and supply agreement for the development and manufacture of immunotherapies by eTheRNA using its proprietary mRNA TriMix platform. PNI’s Clinical Solutions team supported eTheRNA...
Read More
Press Release

Jun 17, 2020

Sirnaomics and Precision NanoSystems Have Formed a Partnership Developing and Manufacturing Novel RNAi drug Candidates Using Precision NanoSystems’ NxGen™ Platform

Sirnaomics Inc. (Sirnaomics) and Precision NanoSystems Inc. (PNI) jointly announced a partnership on the development and manufacture of Sirnaomics polypeptide nanoparticle-based RNAi therapeutic product. This strategic joint effort includes the execution of a NanoAssemblr^&re...
Read More
Press Release

May 20, 2020

CanSino Biologics and Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine

mRNA Vaccines

CanSinoBIO will license in Precision NanoSystems' proprietary RNA vaccine platform technology. Precision NanoSystems will lead RNA vaccine formulation development. CanSinoBIO will lead COVID-19 antigen design, pre-clinical testing and clinical trials

Read More
Press Release

May 07, 2020

Entos and Precision NanoSystems Partner to Enable GMP Manufacturing of DNA COVID-19 Vaccine | EurekAlert

DNA Other Formulations Vaccines

Entos Pharmaceuticals partners with Precision Nanosystems to enable highly scalable GMP manufacturing of Fusogenix DNA COVID-19 vaccine and other genetic nanomedicines
Read More
Press Release

Apr 14, 2020

Precision NanoSystems Appoints Dr. Andrew Geall as Chief Scientific Officer

mRNA

Precision NanoSystems (PNI), a global leader in enabling transformative nanomedicines today announced the appointment of Dr. Andrew Geall as the company’s Chief Scientific Officer (CSO). Dr. Geall has over 20 years’ experience in the development of drug deliv...
Read More
Press Release

Mar 24, 2020

Precision NanoSystems Announces Partnership with Fujifilm for the Development and GMP Manufacturing of Nanoparticle Based Therapeutics

Formulation Application Payload

Vancouver BC, March 24, 2020 Precision Nanosystems, Inc. (PNI), a global leader in enabling transformative nanomedicines announced today that the company entered into a license agreement with FUJIFILM Corporation to adopt PNI’s NanoAssemblr™ technology and co...
Read More

IN THE NEWS

News Article

Mar 16, 2020

NIH Clinical Trial of Investigational Vaccine for COVID-19 Begins

Vaccines mRNA

The NIH and Moderna have begun phase 1 clinical trials for a vaccine to protect against COVID-19. The vaccine, called mRNA-1273, is an advanced mRNA vaccine that utilizes genetic material to immunize patients. Moderna and the NIH were able to bring mRNA-1273 to clinical trials wi...
Read More
News Article

Jul 30, 2018

Simplifying Nanomedicine Manufacturing for the Masses - BioWorld

Precision Nanosystems' Nanoassemblr technology uses microfluid continuous flow to control variables in the assembly of the nanoparticles. The company has three machines available that can scale depending on which stage of discovery a compound is in...
Read More
News Article

Apr 20, 2018

In Full Boom -Two Vancouver-based companies are creating industry leading research tools and technology and helping B.C. stake its claim as a world-class burgeoning biotech hub.

Two Vancouver-based companies are creating industry leading research tools and technology and helping B.C. stake its claim as a world-class burgeoning biotech hub. Precision NanoSystems Inc. (PNI) and Stemcell Technologies Inc. are just two of a gr...
Read More
News Article

Dec 20, 2017

Precision NanoSystems Named as One of British Columbia’s Fastest Growing Companies | Business Wire

Precision NanoSystems is one of the fastest growing businesses in British Columbia (BC) according to the recently published Top 100 fastest-growing companies in BC list from business news journalBusiness in Vancouver&nbs...
Read More
News Article

Nov 23, 2017

Precision NanoSystems to Host Nanomedicines Roundtable | Nanotechnology Now

Join Precision NanoSystems for a roundtable discussion on nanomedicines as part of the 3rd International Electronic Conference on Medicinal Chemistry. Organised by Pharmaceuticals journal, this free online conference runs until November 30th, and d...
Read More
News Article

Oct 20, 2017

Nanomedicines - Exploring the Past, Present and Future

The commercial availability of microfluidic platforms aimed specifically at drug formulation is helping to lower the barriers to nanomedicine research. Implementation of this technology eliminates the need for in-house microfluidics expertise and e...
Read More

LATEST NEWS

PRESS RELEASES

IN THE NEWS

Stay Informed